Improvements to quality of life and safety for people with swallowing difficulties following analysis of fluid thickeners
Submitting Institution
University College LondonUnit of Assessment
Psychology, Psychiatry and NeuroscienceSummary Impact Type
HealthResearch Subject Area(s)
Medical and Health Sciences: Clinical Sciences, Public Health and Health Services
Summary of the impact
Swallowing disorders (dysphagia) result in prolonged hospital stays and
can lead to death. An important method in the management of dysphagia is
the use of fluid thickeners. Fluid thickeners both slow the flow of fluid
through the oropharynx and increase the sensory input to mediate
swallowing, thus increasing safety. Research at UCL's Language and
Communication Research Department has led to improvements in the
development and standardization of fluid thickeners, the training of
healthcare workers who prepare them, and increased understanding for
industry, healthcare and patients. The results are used in the development
of new commercial thickeners, refinement of current commercial thickeners,
training industry employees, development of international guidelines for
dysphagia management, training NHS staff, and prescribing thickeners for
people with dysphagia.
Underpinning research
Dysphagia is the term used to describe disorders that affect our ability
to eat, drink and swallow. It is a global disability affecting
approximately 14% of people over the age of 60 years, 40-78% of people
post stroke, 20-40% of people with Parkinson's disease, and is found in
20% of the general elderly primary care population. It also affects
children, most notably those with cerebral palsy and Down's syndrome. The
potential problems of choking, chronic aspiration, malnutrition and
dehydration can be fatal, and have a profound impact on quality of life.
Persistent swallowing problems add significantly to delay in discharge
from hospital (adding to NHS costs) with some nursing homes unwilling to
accept patients who are fed through a nasogastric tube.
An important technique in the management of swallowing disorders is
modifying a person's diet by changing the thickness/viscosity of foods and
drinks through the addition of commercially available powders. Almost all
individuals with dysphagia will be prescribed a thickening powder, with
some people using thickeners over many years.
In the laboratory, Drs Christina Smith and Ben Hanson examined the flow
behaviours of thickened drinks during their preparation by carers and over
the time period when drinks may be left for a patient to consume them.
This work corroborated carers' subjective impressions of continued
thickening over time and was additionally able to quantify the degree of
thickening at different times after preparation allowing carers and
patients to know the thickness of their drinks at different times [1].
Following on from this research, thickened drinks were prepared using
instructions provided on the packaging of thickener products and these
were compared with the terminology provided by the National Descriptors
developed by professional bodies (Royal College of Speech and Language
Therapists, British Dietetics Association and National Patient Safety
Agency). This study clarified for professionals how to prepare drinks
using thickeners and recommended following product guidelines for
thickening water rather than using unreliable subjective judgements such
as visualising the product [2]. As well as publication in academic
journals, a summary of both papers was also produced for a professional
magazine to maximise the information dissemination [3].
Smith and Hanson further demonstrated how thickened drinks change during
swallowing as a result of salivary amylase, with some thickeners returning
to their unthickened state [4]. They then went on to propose a
solution to preserve the thickened drink, thus maximizing patient safety.
Examining behaviour of the two (starch-based and gum-based) primary groups
of commercially available thickeners and how they change depending upon
the base fluid, they demonstrated a 10-fold difference in the thickness
of a drink (white wine being the thinnest and lemon barley water the
thickest) with the addition of the same quantity of thickening powder [5].
The work described above has clear implications for the preparation of
drinks for people with swallowing difficulties. The research has been used
by industry in training (Fresenius Medical Care), product description
(Nutilis and Fresenius Medical Care) and ongoing product development
Nutilis and Fresenius Medical Care). It has attracted UK research council
and industry funding. It has altered clinical practice by clarifying for
industry and clinicians the critical issues in the use of thickeners as a
therapeutic intervention.
References to the research
[3] Smith CH, Hanson B (2011) Understanding thickeners, RCSLT Bulletin,
May 2011. Available on request.
[5] Hanson B, Cox B, Kaliviotis E, Smith CH. Effects of Saliva on
Starch-Thickened Drinks with Acidic and Neutral pH. Dysphagia. 2012
Sep;27(3):427-35. http://dx.doi.org/10.1007/s00455-011-9386-5
(163 downloads in 30 days reported in letter from publisher)
Grants
Smith CH & Hanson B. 2012-2015. Prescribed diets: quantifying the
effect of mechanical consistency on health, patient safety, and quality of
life. UK Research Council — Crucible Centre for Lifelong Health and
Wellbeing, £86,000.
Hanson B & Smith CH. 2012-2015. `Understanding Flow Properties of
Thickened Drinks'. Heath Engineering for an Ageing Population, and
Fresenius Medical Care, £75,617.
Hanson, B. 2008-2010. `A self-sensing instrument for investigation of
rheology in dysphagia'. EPSRC, £207,000.
Details of the impact
Our programme of research into thickened drinks used in clinical practice
has had an influence on commercial products for dysphagia, and on the
practitioners using these products. Both of these factors have resulted in
increased benefit for patients with dysphagia.
Impact on the manufacturers of drink thickeners.
Our research has been utilised by all three of the companies producing
thickening products (Fresenius Kabi, Nutricia and Nestlé), both through
direct use and citation of our research, and via our training of their
product developers and representatives (for example at the European
Society for Swallowing Disorders 2012, and BAPEN 2012). These companies
have utilised our work in the development of new products, in the
refinement of existing products, in the training of their employees and in
the training of healthcare providers. In addition it has been used in
their discussions with NHS staff who procure these products for use in
individual health trusts. (Every NHS Trust uses these products, and the
total market value is around £12-15m per annum [a].)
Fresenius Kabi cite our research throughout an `advertorial' for their
product, Thick and Easy [b]. This has been used in international
journals such as Dysphagia, and also the professional magazine from the
Royal College of Speech and Language Therapists. Fresenius also report
that the research has been used in product development:
"The research has also helped us start some new product development
projects by giving us the improved information around the products
available in the market" [c].
Nutricia have also cited one of our papers in an advert for their Nutilis
range [d]. They report that:
"The findings from [O'Leary et al 2010] helped Nutricia to develop an
internal standard for viscosity, which has enabled Nutricia to
objectively measure viscosity when determining the different stages of
our dysphagia products (Nutilis Range)... Nutricia have used the
research from Dr Christina Smith and colleagues to improve the standards
of the Nutilis range, which is designed to benefit the care of patients
living with dysphagia" [e].
The improvements to the thickening products, as described by the
companies have resulted in a better product used in healthcare. In
addition, the improvements are reflected in the clarity of their
advertising.
Impact on clinical practice through training of healthcare providers.
As mentioned above, companies have used our work in the training of
healthcare providers. Many of these companies provide extensive training
and education to healthcare staff who make thickened drinks for patients.
Fresenius Kabi, for example, report that:
"Research at UCL by Dr Christina Smith and colleagues has revealed
that there are a number of misconceptions around thickening drinks that
have led to products being misunderstood and potentially affecting
practice carried out by Speech and Language Therapists. The findings
have been incorporated into our training sessions to ensure correct
usage of the products and increased understanding into how liquids and
thickeners work together allowing health care professionals and patients
to use our products with better knowledge around the way the product
works which ultimately improves practice" [c].
The more carefully this training is provided with increased knowledge of
the behaviours of the thickening products, the better provision for
patients.
We have also directly trained healthcare workers through study days (such
as the adult dysphagia special interest group in June 2011; the Scottish
Speech and Language Therapists Special Interest Group in April 2013) and
practical symposia at conferences (e.g. European Society for Swallowing
Disorders, October 2012) [f].
Resulting impacts on patients
Our research into the behaviours of thickening products providing clearer
information on the use of these products has influenced the prescribing to
individuals with swallowing difficulties. For example, a Speech and
Language Therapist at University Hospital Lewisham reported that the
hospital had changed their use of the products as a direct result of the
research [g].
The international reach of the research is demonstrated the International
Dysphagia Diet Standardisation Initiative (IDDSI) which is utilising the
results in setting forth their guidelines.
Sources to corroborate the impact
[a] Details of market value and trusts using drinks thickeners provided
by Senior Product Manager, Fresenius Kabi. Copy of email available on
request.
[b] Fresenius advertorial. References Hanson et al 2011 and O'Leary et al
2011 throughout. Copy available on request.
[c] Letter of endorsement from Fresenius Medical Care. Copy available on
request.
[d] Advert for the Nutilis range. References O'Leary et al 2010. Copy
available on request.
[e] Letter of endorsement from Nutricia. Copy available on request.
[f] Copies of conference programmes available on request.
[g] Email from SLT, University Hospital Lewisham. Copy available on
request.